Updated: January 21, 2026
EstroGel Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
- Is EstroGel Officially in Shortage?
- What Is Causing the Availability Problem?
- The HRT Demand Surge Following the FDA's 2025 Decision
- The Estradiol Patch Shortage Redirected Demand to Gels
- Pharmacy Stocking Practices Haven't Kept Up
- What Does This Mean for My Prescription?
- What Should I Do If I Can't Find EstroGel?
- Is There a Timeline for When This Will Improve?
EstroGel isn't on the FDA shortage list, but patients are struggling to find it. Here's what's actually happening in 2026 and what to do about it.
If your pharmacist has told you EstroGel is on backorder or unavailable, you may be wondering: is this an official shortage? What's causing it? How long will it last? And most importantly — what do you do now? This article gives you a straightforward update on EstroGel availability in 2026 and clear next steps.
Is EstroGel Officially in Shortage?
As of 2026, EstroGel (estradiol 0.06% gel) is NOT on the FDA's official drug shortage list. ASCEND Therapeutics, the manufacturer, has not announced a production halt or supply disruption for EstroGel. The FDA's drug shortage database — which tracks medications where supply cannot meet demand at the national level — does not include EstroGel among its entries.
However, "not in official shortage" doesn't always mean "easy to find." Thousands of patients across the country are reporting difficulty filling EstroGel prescriptions at their local pharmacies — and their experience is valid. Understanding why this is happening requires looking at the broader HRT market in 2026.
What Is Causing the Availability Problem?
Several interconnected factors have converged to strain EstroGel's availability in 2026:
The HRT Demand Surge Following the FDA's 2025 Decision
In November 2025, the FDA made a landmark decision to remove the black box warning from bioidentical transdermal estradiol products, including gels, patches, and creams. This warning — in place for over two decades since the Women's Health Initiative study — had long discouraged both patients and providers from using HRT. Its removal triggered an immediate and significant increase in HRT prescriptions. Providers who had been hesitant became more comfortable prescribing, and many women who had delayed or avoided HRT began therapy.
The Estradiol Patch Shortage Redirected Demand to Gels
At the same time, estradiol transdermal patches — including Climara, Vivelle-Dot, Dotti, Lyllana, and generics from Sandoz, Mylan, and Zydus — have been experiencing a major nationwide shortage. CVS confirmed to NPR that manufacturers have been unable to provide sufficient supplies. With patches unavailable, prescribers turned to the next best transdermal option: gels. EstroGel and Divigel absorbed a significant wave of patients who had previously been on patches, dramatically increasing demand.
Pharmacy Stocking Practices Haven't Kept Up
EstroGel is not a high-volume, ubiquitous medication like a blood pressure drug or antibiotic. Many pharmacies — especially smaller chain locations and those in less urban areas — don't stock it routinely. They order it on demand. When demand jumps suddenly, reorder cycles take time, leaving gaps on the shelf that patients experience as a "shortage" even if the manufacturer still has inventory.
What Does This Mean for My Prescription?
If your local pharmacy can't fill your EstroGel prescription, here is what the situation actually means:
Your specific pharmacy may be out of stock — but other pharmacies in your area may have it. The problem is often localized, not universal.
Independent pharmacies and mail-order pharmacies often have better access than large chains during periods of elevated demand.
The situation is likely temporary, tied to a demand spike that should normalize as pharmacies adjust their reorder quantities and as estradiol patch supply recovers.
What Should I Do If I Can't Find EstroGel?
Here are the most effective steps to take right now:
Use medfinder: Visit medfinder.com to have pharmacies near you searched for EstroGel availability. This saves you the time of calling dozens of pharmacies.
Call your provider: Let them know you can't fill your prescription. They may be able to call ahead to a pharmacy they know has stock, or write a prescription for an equivalent alternative.
Try independent pharmacies: Locally owned pharmacies often have more sourcing flexibility than CVS, Walgreens, or Rite Aid.
Ask about mail-order: Your insurance's mail-order pharmacy may be able to fill a 90-day supply and ship it to you directly.
Don't stop therapy abruptly: Stopping HRT suddenly can cause a rapid return of hot flashes, night sweats, sleep disruption, and mood symptoms. Always discuss any interruption with your prescriber.
Is There a Timeline for When This Will Improve?
Because EstroGel is not in an official manufacturing shortage, a resolution depends primarily on pharmacies adjusting their inventory practices to reflect the new, higher baseline demand for HRT. As the estradiol patch shortage resolves — which manufacturers are working on — some of the overflow demand on gels should ease. The HRT market broadly is stabilizing, but this will take months, not weeks.
For alternatives while you search, see Alternatives to EstroGel If You Can't Fill Your Prescription. For help locating stock, see How to Find EstroGel in Stock Near You.
Frequently Asked Questions
No. As of 2026, EstroGel is not listed on the FDA's official drug shortage database. ASCEND Therapeutics has not announced manufacturing disruptions for EstroGel. The availability challenges patients are experiencing stem from a demand surge — not a manufacturing shortage — driven by the November 2025 removal of the HRT black box warning and the overflow from the estradiol patch shortage.
It's difficult to predict a specific timeline. The demand surge from the FDA's 2025 HRT label change should gradually stabilize as pharmacy ordering catches up with the new baseline. The estradiol patch shortage, which is pushing patients toward gels, is expected to continue through much of 2026. EstroGel availability should improve as both of these pressures ease.
Yes. EstroGel's formulation has not changed. ASCEND Therapeutics manufactures it at the same 0.06% concentration, and each pump depression still delivers 0.75 mg of estradiol. If you can find it in stock, it will work exactly as it always has.
The FDA removed the black box warning from bioidentical transdermal estradiol products in November 2025 after reviewing updated evidence showing that the original warning — based largely on the 2002 Women's Health Initiative study — had overstated the risks of transdermal, bioidentical estradiol relative to the synthetic hormones studied. The new labeling places these risks in the Warnings & Precautions section, where they can be discussed in proper clinical context.
Never stop hormone therapy abruptly without talking to your doctor. Stopping HRT suddenly can cause a rapid return of vasomotor symptoms like hot flashes and night sweats, as well as sleep disruption, mood changes, and increased risk of bone loss with prolonged interruption. Contact your prescriber as soon as you anticipate a gap in your supply, so they can help you bridge with an alternative.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsRelated articles
30,682 have already found their meds with Medfinder.
Start your search today.

![Who Has Vyvanse in Stock Near You? Find It Today [2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F1079f61f167dcbc2ed5f1da17a0dcb0b7166357e-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)


